Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001185185-20-000892
Filing Date
2020-06-25
Accepted
2020-06-24 19:31:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A dangdai20200624_sc13da.htm SC 13D/A 51554
  Complete submission text file 0001185185-20-000892.txt   53370
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Subject) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82437 | Film No.: 20986740
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 369 LUMO ROAD HONGSHAN DISTRICT WUHAN, HUBEI F4 430070
Business Address 369 LUMO ROAD HONGSHAN DISTRICT WUHAN, HUBEI F4 430070 86-027-87596552
Dangdai International Group Co. Ltd (Filed by) CIK: 0001678024 (see all company filings)

EIN.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13D/A